These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15069067)

  • 1. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states.
    Standaert ML; Sajan MP; Miura A; Kanoh Y; Chen HC; Farese RV; Farese RV
    J Biol Chem; 2004 Jun; 279(24):24929-34. PubMed ID: 15069067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance.
    Sajan MP; Standaert ML; Rivas J; Miura A; Kanoh Y; Soto J; Taniguchi CM; Kahn CR; Farese RV
    Diabetologia; 2009 Jun; 52(6):1197-207. PubMed ID: 19357831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
    Sajan MP; Ivey RA; Lee MC; Farese RV
    J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes.
    Farese RV; Sajan MP; Standaert ML
    Exp Biol Med (Maywood); 2005 Oct; 230(9):593-605. PubMed ID: 16179727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific differences in activation of atypical protein kinase C and protein kinase B in muscle, liver, and adipocytes of insulin receptor substrate-1 knockout mice.
    Sajan MP; Standaert ML; Miura A; Kahn CR; Farese RV
    Mol Endocrinol; 2004 Oct; 18(10):2513-21. PubMed ID: 15256535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
    Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
    Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities.
    Tremblay F; Lavigne C; Jacques H; Marette A
    Diabetes; 2001 Aug; 50(8):1901-10. PubMed ID: 11473054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting insulin dose-dependent defects in activation of atypical protein kinase C and protein kinase B/Akt in muscles of obese diabetic humans.
    Casaubon L; Sajan MP; Rivas J; Powe JL; Standaert ML; Farese RV
    Diabetologia; 2006 Dec; 49(12):3000-8. PubMed ID: 17028898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
    Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
    Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective activation of atypical protein kinase C zeta and lambda by insulin and phosphatidylinositol-3,4,5-(PO4)(3) in skeletal muscle of rats following high-fat feeding and streptozotocin-induced diabetes.
    Kanoh Y; Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Farese RV
    Endocrinology; 2003 Mar; 144(3):947-54. PubMed ID: 12586772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle insulin resistance in obesity-associated type 2 diabetes in monkeys is linked to a defect in insulin activation of protein kinase C-zeta/lambda/iota.
    Standaert ML; Ortmeyer HK; Sajan MP; Kanoh Y; Bandyopadhyay G; Hansen BC; Farese RV
    Diabetes; 2002 Oct; 51(10):2936-43. PubMed ID: 12351430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-stimulated plasma membrane association and activation of Akt2, aPKC zeta and aPKC lambda in high fat fed rodent skeletal muscle.
    Herr HJ; Bernard JR; Reeder DW; Rivas DA; Limon JJ; Yaspelkis BB
    J Physiol; 2005 Jun; 565(Pt 2):627-36. PubMed ID: 15802290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats.
    Tremblay F; Lavigne C; Jacques H; Marette A
    Diabetes; 2003 Jan; 52(1):29-37. PubMed ID: 12502490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.
    Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
    Endocrinology; 2001 Apr; 142(4):1595-605. PubMed ID: 11250941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.
    Sajan MP; Standaert ML; Nimal S; Varanasi U; Pastoor T; Mastorides S; Braun U; Leitges M; Farese RV
    J Lipid Res; 2009 Jun; 50(6):1133-45. PubMed ID: 19202134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle.
    Temofonte N; Sajan MP; Nimal S; Pastoor T; Fumero C; Casaubon L; Powe JL; Standaert ML; Farese RV
    Diabetologia; 2009 Jan; 52(1):60-4. PubMed ID: 18972094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects.
    Sajan MP; Standaert ML; Miura A; Bandyopadhyay G; Vollenweider P; Franklin DM; Lea-Currie R; Farese RV
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3994-8. PubMed ID: 15292339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes.
    Miura A; Sajan MP; Standaert ML; Bandyopadhyay G; Kahn CR; Farese RV
    Biochemistry; 2004 Dec; 43(49):15503-9. PubMed ID: 15581362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
    Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
    Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice.
    Hori H; Sasaoka T; Ishihara H; Wada T; Murakami S; Ishiki M; Kobayashi M
    Diabetes; 2002 Aug; 51(8):2387-94. PubMed ID: 12145149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.